What did @thebotoxking actually say?
Honestly? It's difficult to pin down a coherent claim here. The transcript appears to be a garbled auto-transcription of Croatian-language audio, producing nonsensical English phrases like "you need to be able to buy a new whiskey" and repeated references to laser temperature. The video is tagged with #ozempicface and originates from a Croatian aesthetic medicine clinic, so the likely topic is treating GLP-1-related facial volume loss with laser or filler procedures. But based purely on what the transcript actually contains, there are no verifiable medical claims to directly quote. What we can do is fact-check the implied premise: that aesthetic clinic procedures address "Ozempic face."
The caption translates roughly to: "If you've faced the same or similar problem, we have a solution for you," which is a soft promotional hook aimed at patients experiencing facial aging from rapid weight loss.
Does the science back up the Ozempic face premise?
Yes, the underlying phenomenon is real and reasonably well-documented. Rapid weight loss, including from GLP-1 agonists like semaglutide, accelerates facial volume depletion in ways that differ from gradual aging. This is not just cosmetic vanity; it reflects genuine structural changes.
A 2023 commentary in JAMA Facial Plastic Surgery (Deeb et al.) noted that patients on GLP-1 medications are presenting more frequently with accelerated facial lipoatrophy, particularly in the midface and temporal regions. The mechanism involves both subcutaneous fat reduction and potential collagen degradation associated with rapid weight cycling. Dermal fillers, particularly hyaluronic acid-based products, and energy-based devices including radiofrequency and laser platforms, have established evidence for restoring facial volume and improving skin laxity. The American Society for Dermatologic Surgery has published consensus guidance on combination approaches for facial rejuvenation, though none specifically address GLP-1 patients as a distinct clinical population yet.
What did they get wrong, or right?
The clinic's general positioning, that aesthetic procedures can address GLP-1-associated facial changes, is not wrong in principle. Where the video fails is in the specifics it doesn't provide. The transcript mentions laser temperature repeatedly, which likely refers to a fractional laser or radiofrequency device. These tools do have evidence behind them for skin tightening, but the evidence varies significantly by device type, energy settings, skin type, and patient age.
What's missing is any acknowledgment that results depend heavily on whether a patient has stabilized their weight before treatment. Treating facial volume loss in someone still actively losing weight on semaglutide is likely to produce suboptimal results, since the tissue baseline keeps shifting. A 2022 study in Aesthetic Surgery Journal (Rohrich et al.) emphasized that patient selection and timing of intervention are the strongest predictors of outcome in facial rejuvenation, not device choice alone. The video implies a straightforward "we have a solution," which glosses over that complexity.
What should you actually know?
If you're on a GLP-1 medication and noticing facial changes, there are a few things worth understanding before booking a clinic appointment. First, the degree of facial volume loss is broadly proportional to the speed and amount of weight lost, not to the drug itself. The drug is accelerating weight loss; the face responds to the weight loss.
Second, timing matters. Most aesthetic medicine practitioners with experience in this area recommend waiting until weight has been stable for at least three to six months before undertaking significant filler or laser procedures. Otherwise you're investing in a moving target. Third, not all procedures carry equal risk or evidence. Hyaluronic acid fillers are reversible with hyaluronidase if results are unsatisfactory. Laser treatments are not reversible, and downtime and complication rates vary by skin type. Any clinic presenting laser as a quick fix without a thorough consultation process should be viewed with skepticism. The promotional framing of this video, a problem-solution hook with no clinical nuance, is exactly the kind of content that can push patients toward premature or inappropriate treatment.